Inventiva IVA
NASDAQ IVA
$4.78 -0.06 (-1.24%)
As of: Sep 4, 2026 · 3:59 PM EDT

Inventiva (IVA) Long-Term Investments (2023 - 2025)

Inventiva (IVA) posted quarterly Long-Term Investments of $275.3 million for Q4 2025, up 157.31% year-over-year from $107.0 million in Q4 2024, and down 70.87% quarter-over-quarter from $945.2 million in Q2 2025.

Analysis

Inventiva (IVA) Long-Term Investments (2023 - 2025) Analysis & Trends

Inventiva's Long-Term Investments history runs 8 years deep, the most recent figure standing at $275.3 million for Q4 2025.

  • In Q4 2025, Long-Term Investments rose 157.31% year-over-year to $275.3 million; the TTM figure through Dec 2025 stood at $275.3 million (up 157.31% YoY), while the FY2025 annual figure was $275.3 million, up 157.31% from the prior year.
  • Long-Term Investments for Q4 2025 stood at $275.3 million, down from $945.2 million in the prior quarter.
  • The five-year high for Long-Term Investments was $945.2 million in Q2 2025, with the low at $955015.7 in Q2 2022.
  • The 5-year median for Long-Term Investments is $68.4 million (2023), against an average of $161.0 million.
  • The sharpest annual moves came in 2023 and 2025: Long-Term Investments sank 51.14% in 2023, then surged 4055.39% in 2025.
  • Inventiva's Long-Term Investments stood at $117.8 million in 2021, then decreased by 22.04% to $91.8 million in 2022, then tumbled by 51.14% to $44.9 million in 2023, then soared by 138.42% to $107.0 million in 2024, then surged by 157.31% to $275.3 million in 2025.
  • Business Quant data shows IVA's Long-Term Investments at $275.3 million in Q4 2025, $945.2 million in Q2 2025, and $107.0 million in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 5.79 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 9.83 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -4.00 Mn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 1.77 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 22.17 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 372.10 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Inventiva 893.85 Mn 893.85 Mn - 613,450.93
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 613,450.93
Jun 30, 2025 945,186.34
Dec 31, 2024 1.22 Mn
Jun 30, 2024 22.75 Mn
Dec 31, 2023 1.53 Mn